Get started
Author

Gentiana Elena Trotta

Observed name: Gentiana Trotta
ORCID: 0009-0005-1021-8235
Observed ORCID: 0009-0005-1021-8235
OpenAlex ID: A5029457633
Secondary primary malignancies after CD‐19 directed CAR ‐T‐cell therapy in lymphomas: A report from the Italian CART ‐ SIE study
2024 · Angelica Barone, Annalisa Chiappella, et al. · British Journal of Haematology · 17
PDF
Fever of Unknown Origin and Multidrug-resistant Organisms Colonization in Aml Patients.
2023 · Luca Guarnera, Gentiana Elena Trotta, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 14
PDF
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation
2024 · Gentiana Elena Trotta, Giulia Ciangola, et al. · Current Research in Translational Medicine · 3
Beyond CAR-T: Preventing and Treating Relapse in B-Cell Haematological Malignancies
2026 · Martina Canichella, Elisabetta Abruzzese, et al. · Cells
The role of morphology in diagnosing MDS with Non-clonal cytopenias
2025 · Gentiana Elena Trotta, Enrico Santinelli, et al. · Leukemia Research
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challenge
2023 · Andrea Nunzi, Giulia Ciangola, et al. · Current Research in Translational Medicine
Real Life Feasibility of a Combined Clinical and Biological Fitness Assessment in Patients with Acute Myeloid Leukemia
2022 · Raffaele Palmieri, Simona Iacobelli, et al. · Blood
Works count: 7
Citation count: 34
H-index: 3
I10-index: 2
Year
Topic
Type